Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
Ebiomedicine
|
November 18, 2023
Centrally and peripherally altered glucose transporters: is it time to revisit energy deficiency as a potential treatment strategy in Huntington's disease?
Maria Björkqvist
Journal of Neurochemistry
|
April 10, 2016
Immunomodulation - a disease-modifying avenue for treatment of Huntington's disease?
Maria Björkqvist
Journal of Huntington'S Disease
|
April 5, 2018
A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward
Edina Silajdžić, Maria Björkqvist
The European Journal of Neuroscience
|
August 24, 2006
Hypothalamic-endocrine aspects in Huntington's disease
Asa Petersén, Maria Björkqvist
Journal of Huntington'S Disease
|
August 7, 2025
Neuroinflammation in Huntington's disease: Causes, consequences, and treatment strategies
Alina Blusch, Maria Björkqvist
BMC Neurology
|
February 6, 2015
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease
Edina Silajdžić, Maria Björkqvist, Oskar Hansson
Acta Paediatrica (Oslo, Norway : 1992)
|
July 13, 2013
Staphylococcus epidermidis and Staphylococcus aureus trigger different interleukin-8 and intercellular adhesion molecule-1 in lung cells: implications for inflammatory complications following neonatal sepsis
Mikael Ivarsson, Jens Schollin, Maria Björkqvist
Expert Review of Neurotherapeutics
|
December 18, 2008
Immune markers for Huntington's disease?
Edward Wild, Maria Björkqvist, Sarah J Tabrizi
Plos One
|
December 5, 2012
No diagnostic value of plasma clusterin in Alzheimer's disease
Edina Silajdžić, Lennart Minthon, Maria Björkqvist, et al.
Neuron
|
October 21, 2009
Harnessing immune alterations in neurodegenerative diseases
Maria Björkqvist, Edward J Wild, Sarah J Tabrizi
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
Ebiomedicine
|
November 18, 2023
Centrally and peripherally altered glucose transporters: is it time to revisit energy deficiency as a potential treatment strategy in Huntington's disease?
Maria Björkqvist
Journal of Neurochemistry
|
April 10, 2016
Immunomodulation - a disease-modifying avenue for treatment of Huntington's disease?
Maria Björkqvist
Journal of Huntington'S Disease
|
April 5, 2018
A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward
Edina Silajdžić, Maria Björkqvist
The European Journal of Neuroscience
|
August 24, 2006
Hypothalamic-endocrine aspects in Huntington's disease
Asa Petersén, Maria Björkqvist
Journal of Huntington'S Disease
|
August 7, 2025
Neuroinflammation in Huntington's disease: Causes, consequences, and treatment strategies
Alina Blusch, Maria Björkqvist
BMC Neurology
|
February 6, 2015
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease
Edina Silajdžić, Maria Björkqvist, Oskar Hansson
Acta Paediatrica (Oslo, Norway : 1992)
|
July 13, 2013
Staphylococcus epidermidis and Staphylococcus aureus trigger different interleukin-8 and intercellular adhesion molecule-1 in lung cells: implications for inflammatory complications following neonatal sepsis
Mikael Ivarsson, Jens Schollin, Maria Björkqvist
Expert Review of Neurotherapeutics
|
December 18, 2008
Immune markers for Huntington's disease?
Edward Wild, Maria Björkqvist, Sarah J Tabrizi
Plos One
|
December 5, 2012
No diagnostic value of plasma clusterin in Alzheimer's disease
Edina Silajdžić, Lennart Minthon, Maria Björkqvist, et al.
Neuron
|
October 21, 2009
Harnessing immune alterations in neurodegenerative diseases
Maria Björkqvist, Edward J Wild, Sarah J Tabrizi
Page
of 8